Archive for the ‘Stocks to Watch’ Category

Miraculins, Inc. (MOM.V) (MCUIF) Revolutionary Scout DS® System Provides Highly Accurate, Non-Invasive Diabetes Screening Methodology

Tuesday, December 16th, 2014

Diabetes is the fastest growing disease in history with some 387M or more cases globally estimated this year by the International Diabetes Federation (IDF), a figure that is set to rise roughly 53% over the next two decades. The most disturbing statistic is the 175M or more of those cases that go undiagnosed. The IDF data paints an alarmingly clear picture, diabetes is on the rise in every country on earth; in fact, one out of every 12 humans has diabetes and one out of every two people with diabetes doesn’t even know they have it. The IDF estimates that as many as 628M people globally are pre-diabetic or have Type 2 diabetes (adult-onset or non–insulin-dependent diabetes), with projections through 2030 indicating a 45% jump to around 912M.

Here in the U.S. we are spending more on healthcare to combat diabetes than anywhere else on the planet, with $612B (or 11% of all healthcare spending on adults) spent in 2014 alone, and the American Diabetes Association’s (ADA) data indicates that not only is diabetes the number seven killer in the country, it was also a leading underreported cause of death. Some 40% of people who died of diabetes did not have it listed anywhere on the death certificate according to ADA’s research, and the Centers for Disease Control and Prevention (CDC) estimates that if this trend continues as many as one out of every three Americans will have diabetes by 2050. Troubling statistics indeed when one considers the nearly 5M fatalities this year in the U.S. from diabetes, or one death every seven seconds.

Last year, over 79k children developed Type 1 diabetes (roughly 10% of all cases, formerly known as juvenile-onset or insulin-dependent diabetes) and over 21M births were affected by diabetes during pregnancy as well. Moreover, despite the incident rate being highest among persons aged 40 to 59 years, some 208k Americans under the age of 20 are estimated to have been diagnosed this year according to the ADA. This clearly documents that Type 2 diabetes, once virtually unheard of in people under 30, is now rapidly on the rise, with childhood obesity playing a major role.

Type 1 diabetes can be averted if caught early and diabetics can even turn the disease around completely with proper diet and exercise, but the high number of undiagnosed cases is a serious red flag here, pointing directly to the costs, complexities and invasiveness of testing. Early detection and intervention is absolutely key to preventing Type 1 diabetes, and with average medical expenditures as much as 2.3 times higher for diabetics than those without it, public health organizations and governments are now starting to get serious about creating initiatives designed to tackle the problem.

Many people go untested due to the invasiveness or daunting logistics of existing testing methods, involving blood draws, fasting, trips to the doctor and/or lab, and waiting for test results to come back. The common A1C test for instance (sometimes also called the HbA1c test), which measures an individual’s average blood sugar level over the past few months, requires a sizeable blood sample and is the most common route for testing. The FPG test (fasting plasma glucose) or the OGTT test (oral glucose tolerance, commonly done to check for diabetes that occurs with pregnancy, or gestational diabetes), while less expensive and generally very easy to do compared to the A1C, are similarly problematic, given that patients must fast for 8 to 14 hours prior to taking the test and must still give a blood sample(s).

People’s reluctance to get tested and the subsequent healthcare costs associated with increased morbidity, may have finally met their match though in the form of the novel, non-invasive Scout DS® system from Miraculins, Inc. (TSX-V: MOM) (OTCM: MCUIF). This first-of-its-kind device is a sleek looking, small form factor tabletop system, featuring an LCD display and an arm rest that the patient places their forearm onto for the test. After only about 80 seconds the device painlessly produces a highly accurate score on a scale from 0 to 100 using a series of LED lights and sensors. The device uses a well-established testing methodology called skin fluorescence spectroscopy (SFS) to measure advanced glycation end products (AGEs), which have been vetted through numerous studies over the past 25 years as a highly sensitive metric for gauging the cumulative impact of abnormally high blood sugar and oxidative stress on the body.

Until recently, AGE measurement required a punch biopsy of the skin big enough to require a stitch and a costly/complex assay for which only a handful of academic laboratories had the capability, making this approach to screening for diabetes essentially non-commercially viable. The Scout DS however uses quantitative SFS (multivariate spectroscopy using a unique algorithm) to measure collagen cross-links and other fluorescent AGEs, via a set of unique UV/Blue LEDs to stimulate fluorescence, as well as some White LEDs to compensate for skin tone variations. With more than 3k subjects to date tested in prospective clinical trials, the accuracy and efficacy of the Scout DS for doing rapid, non-invasive screening of pre-diabetes and Type 2 diabetes, by measuring diabetes related biomarkers in the skin, now looks to be firmly established.

The efficacy of this rapid testing technology was even recently demonstrated in a peer-reviewed study (ENGINE) of the Scout DS published in the Journal of Clinical and Translational Endocrinology. The study showed the device’s ability to detect abnormal glucose tolerance just as well as (if not better than) FPG or A1C testing, all without fasting or blood draws, adding further credence to the commercial viability of the Scout DS as a rapid non-invasive screening system for diabetes, as well as the accuracy and robustness of the innovative SFS/AGE testing methodology which lies at the heart of the device’s design. The Scout DS is 61% more sensitive than A1C and 100% more sensitive than FPG (ENGINE study), with a 93% detection rate for Type 2 diabetes (TCOYD1 study), and is 1.4 times better than RCG with an equivalent false-positive rate (random capillary glucose, Greece study), yet the device easily works on people with dark skin (LSS study versus OGTT).

In China, which has overtaken India as the world leader in diabetes cases, with upwards of 92M diabetics (again, nearly half of whom are undiagnosed), there is a massive target market for such a device as the Scout DS. Miraculins hasn’t wasted any time acquiring inroads to this target-rich environment and executed a definitive agreement in August to sell and distribute up to $90M worth of Scout DS devices via Hong Kong-based Catalyn Medical Technologies, Ltd., with Cachet Pharmaceutical Co., Ltd. already tapped as exclusive distributor for mainland China.

Also in August, Miraculins detailed their fast-track strategy for obtaining de novo FDA classification (intended for “novel” devices with a low risk profile) on the Scout DS, with a pre-submission designed to follow up on last year’s filing for feedback from the FDA regarding a clinical/regulatory roadmap for marketing clearance, in light of the reasonable assurance of safety and effectiveness of the device, as well as the absence of any existing or comparable device on the market. Obtaining de novo status from the FDA would put the Scout DS on the road to a Class I or Class II medical device classification (cheaper and easier than a Class III designation) and confidence is high at Miraculins that the FDA will be cooperative, especially when the planned data to be gathered and submitted is supplied.

For more information, visit www.miraculins.com

Receive a Daily List of the Best Investment Newsletter Recommendations

Monday, December 15th, 2014

QualityStocks provides online tools and resources to connect subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer many tools to execute this mission, but one of the most liked is our daily Top 3 List.

The Top 3 List allows investors subscribed to The QualityStocks Daily to quickly see which newsletters picked the best performing stocks of the day, saving you time and potentially money you’re missing out on.

To sign up now, visit http://signup.qualitystocks.net

With The QualityStocks Daily, you don’t have to wade through the countless investment newsletters to find the day’s top stock picks. We filter out the newsletters making the right call and deliver them right to your inbox.

And as always, subscribers also have access to The QualityStocks Daily Chart, a collation of each day’s picks from the more than 850 investment newsletters we’re tracking every day.

Let us hear your thoughts below:

eCareer Holdings, Inc.’s (ECHI) Strategy to Advance Newly Enhanced Job Site, Openreq™

Wednesday, December 3rd, 2014

eCareer Holdings is a developer and marketer of branded niche career content sites. The company’s goal is to provide effective job advertising platforms utilizing the latest technologies, addressing the growing demand for skilled professionals in specific sectors. eCareer opened the initial version of a site of this nature, Openreq™ (www.openreq.com), on January 1, 2013.

Openreq, an aggregator of human resources, staffing and recruiting professionals, is a content-driven career community featuring a plethora of career-relevant news, stories, videos and blog posts in what the company calls a “career-inspiring format.” The purpose of the content is to keep job seekers informed about their preferred industry, inspire them about their work, and offer information and opportunities for career advancement.

As with other job sites, job seekers using Openreq can create a profile, submit a resume and receive job alerts and matches. Similarly, employers can post jobs on Openreq and receive candidate matches and alerts. What sets Openreq apart from other job sites is its cutting-edge job matching technology.

Last month, eCareer re-launched Openreq to include superior technology and targeted distribution powered by RealMatch. Now, employers who post jobs on Openreq’s job board can receive “unprecedented outreach” to HR, staffing and recruiting professionals in the Openreq community and on the TheJobNetwork™, the largest recruitment ad network of job sites in North America. Openreq enables hiring managers to automatically screen, grade and rank applicants, and returns qualified passive job seeker matches in real-time from the site’s resume database.

TheJobNetwork reaches millions of active and passive job seekers each month. To maximize qualified response, jobs posted on Openreq are automatically optimized, distributed, and monitored as part of targeted ad campaigns. This results in higher rankings in search results, search engines and paid job sites – thereby increasing qualified response by an average 200%.

Real-Time Job Matching technology instantly matches job seekers to open postings based on their skill set, experience and preferences. This eliminates the need for seekers spend time keyword searching and browsing through hundreds of irrelevant job postings. Furthermore, since Openreq is part of TheJobNetwork, job seekers have access to job matches from any of the thousands of network sites.

eCareer’s business strategy is to provide users free access to the site. Revenue is generated through advertising, resume searches and a job board function. In a recent 10k filing the company states that it previously “strategically delayed sales efforts and initiated sales personnel layoffs in order to focus on the completion of the re-launched Openreq site and enhancements.”

With Openreq now firing on all cylinders, the company in its November 2014 shareholder update further explained its potential and strategy moving forward.

“It’s with great pleasure to report that the new software has really been a tremendous improvement and a leap in the right direction,” said Griffin Karr, client delivery manager.

According to the shareholder update, eCareer’s next step is building direct traffic to Openreq and adding value to the site. eCareer anticipates doing this by promoting the site via the company’s existing social network accounts and thousands of followers; launching a major email blast campaign; performing content marketing; and curating stories from reputable sources to create hundreds of credible backlinks and improve search engine presence/ranking.

“An important thing to note is that the above strategies are all functions we can perform in-house with our existing staff without hiring outside marketing or consulting firms and without incurring additional costs … the site and the technology is working and gives us a lot of confidence that we have turned a huge corner going forward with Openreq and we’re totally focused on ramping up sales and revenue,” stated Joe Azzatta, CEO and founder of the company.

Azzatta added that in Q1 2015, the company plans to bolster Openreq sales staff in Q1 2015; report Openreq, traffic, and revenue statistics; as well as launch www.cardiology.com for the cardiology sector.

To hear the full shareholder update visit www.vimeo.com/111577408

For more information on the company visit www.ecareer.com

Aspen Group, Inc. (ASPU) Gains Traction with Student Body Growth, Increased Revenues, Improved Balance Sheet

Wednesday, December 3rd, 2014

According to the College Board, the average cost of tuition and fees for the 2013–2014 school year was $30,094 at private colleges; $8,893 for state residents at public colleges; and $22,203 for out-of-state residents. For many Americans, as well as international students, the price tag of a college education is often hinged to a high-interest student loan that can take years to pay off.

Aspen Group, an accredited provider of online postsecondary education, strives to provide distance-learning education opportunities to equip students with “sustainable economic and social benefits for themselves and their families.” The university does so by offering low tuition rates on courses taught by Top-tier faculty, 61% of which have doctoral degrees. “Low tuition rates” is relative – but according to Aspen’s Economic Responsibility Goal, the group offers tuition rates low enough that a majority of its students can pay the tuition in cash (maintaining Federal Financial Aid revenues below 50%).

Online education is gaining widespread acceptance, especially among working professionals that choose not to, or are not able to, stop working to obtain a postsecondary education. Online flexibility enables students to enroll in courses taught by instructors with advanced degrees and log on day or night to “attend” class from anywhere with an Internet connection. Students can network with other students, interact with respected technology leaders and fellow professors from around the world, or enroll in courses facilitated one-on-one with the instructor.

Another advantage to online learning vs. traditional learning is the ability to participate in a discussion rather than follow a lecture or presentation. Instructors at Aspen University work closely with students to create an online, community-based learning environment. In this sense, faculty serves as facilitators rather than the focal point. Textbooks and online study guides assist students in performing coursework that is submitted to the faculty for grading a feedback via Aspen University’s proprietary online platform.

Aspen University offers education to students across the U.S. and around the world and accepts credits from other accredited institutions as well as schools outside the U.S. The university provides its students with access to ProQuest library services with databases focused on business, technology, nursing, criminal justice and education.

As of July 30, 2013, 86% of Aspen University’s full-time degree-seeking students are enrolled in a graduate degree program (master’s or doctoral degree program). Aspen University is increasingly gaining traction among adults seeking higher education, and as of Aspen Group’s fiscal 2015 second quarter ended October 31, 2014, the university’s School of Nursing student body increased 71% to 1,026, accounting for 37% of the university’s total full-time degree-seeking student body of 2,811.

Aspen University’s growing presence is further evidenced by the company’s ability to grow revenues, trim net loss, and strengthen its balance sheet.

Second-quarter fiscal 2015 total revenues increased 33% to $1.2 million compared to the second quarter of fiscal 2014; nursing program revenues rose to $483,050, or 40% of Aspen Group’s total revenues. Adjusted gross profit (non-GAAP) increased 67% to $800,921, or 66% of revenues, compared to the second quarter of fiscal 2014. The second quarter non-GAAP fiscal 2015 loss of $228,819 narrowed compared to a loss of $707,501 in the comparable prior-year period.

Aspen Group closed a $5.4 million private placement of equity securities in the second quarter of fiscal 2015, substantially improving the company’s balance sheet. The company retired early its outstanding institutional convertible debentures, improved its cash position to $3 million and increased its stockholders equity to a positive $1.8 million.

In addition, the university achieved several other important benchmarks, including a 33% decrease in the cost per new degree-seeking enrollment – now at a record low of $544; and Aspen’s Bachelor of Science in Nursing Program (RN to BSN) received accreditation from the Commission on Collegiate Nursing Education (CCNE).

Aspen Group chairman and CEO Michael Mathews in a recent news release offered the following:

“The closing of our $5.4 million equity financing and the granting of accreditation of our RN to BSN program by the CCNE are two important milestones that will allow Aspen to scale its debtless education solution. We’ve now removed all roadblocks to achieving our near-term goal of communicating to all RNs in America that they now have the ability to earn a BSN or MSN debt free,” he stated.

For more information, visit www.aspen.edu

Mobile Lads Corp. (MOBO) – Enabling Secure Wide-Area Communication Globally

Monday, November 24th, 2014

Since 2013, Mobile Lads has steadily acquired technology and intellectual property assets to strengthen its position as a leading provider of wireless transaction software solutions and to facilitate wide-area communication on a global scale.

Mobile Lads generates new process improvements and income by developing and delivering specialized, secure wide-area wireless transaction software solutions for customer-focused organizations. The company serves movie theatres, spa hotels, amusement parks, concerts, sports events, and other midsize businesses and, with a suite of patented, mobile authentication and payment products, provides streamlined, continuous access to time-sensitive information and data on multiple network standards.

Mobile Lads’ product offerings include software and associated patents that cover mobile payment authentication and processing. These products, which utilize one of the best cryptographic services and are compliant with all available platforms, simplify and secure wireless communications. Three key pieces of technology provided by Mobile Lads include:

1. xmOne offers assorted, encrypted mobile services, including payment processing, marketing, prepaid account top-up and emergency notification, for students and higher education facilities. The platform interfaces with a school’s existing campus card account system, and allows students to complete banking transactions with their cell phones and educational institutions to benefit from features such as the increased use of their flex-dollar systems.

2. xmBilling provides users with a convenient, protected means of reviewing and approving automatic billing transactions, thus alleviating the challenges of volume-based and automated billing. From notification to review to authorization to ad-hoc payment, xmBilling helps customers make on-time payments.

3. xmVerify is Mobile Lads’ signature software offering. A real-time mobile transaction security service that hinders credit card fraud, xmVerify gives users making purchases control over their payment authorization process.

For more information, visit www.mobilelads.com

Let us hear your thoughts: Mobile Lads Corp. Message Board

LD Micro Main Event: VII is Just around the Corner – Stay Tuned to DTN for Conference Coverage

Friday, November 21st, 2014

More than 230 publicly traded companies are scheduled to follow-up the Thanksgiving holiday with presentations at the highly anticipated investor conference, LD Micro Main Event: VII. From December 2-4, companies from a wide breadth of industries will convene in Los Angeles to network and make connections with several hundred investors.

For more than 12 years, LD Micro has helped micro-cap companies in traditional and emerging markets make a name for themselves in the investment community. The seventh annual Main Event conference agenda includes panel discussions, a keynote presentation by LD Micro founder Chris Lahiji, and an evening of cocktails to create an environment of innovation, networking and discussion.

From well-recognized names in the micro-cap space to lesser-known companies ready to put their name on the map, Main Event will feature high-potential plays with innovation, ideas and developments that add value to the broader market.

For those in the investment community that won’t be attending the conference, not to worry. DreamTeamNetwork (DTN) will provide real-time coverage as each presenting company starts their presentation over the course of the three-day event. As an official conference sponsor, DTN will utilize its vast social media network to keep shareholders informed on who’s who at Micro Event: VII.

For more information visit www.LDMicro.com

American Cannabis Company, Inc. (AMMJ) Positioned as Solid Partner for Penetrating Legal Cannabis Frontiers

Friday, November 21st, 2014

Approximately two years ago, voters in Colorado and the state of Washington made historic decisions to legalize marijuana for recreational sale and use, running counter to the position of anti-pot moralists, four star generals in the war on drugs and 100 years of prohibition. In January 2014, these policies began to take effect, with pot shops opening for business for the first time from sea to shining sea.

Decriminalization One State at a Time

Once regularly joked about, legalization now appears to be an undeniable reality. In mid-April of this year, no fewer than eleven states were considering some form of legislation to allow marijuana to be sold over the counter, and at least a dozen others are considering medical and/or commercial decriminalization. Tired of the U.S. government running in place on the progress treadmill, many states are cautiously weighing the potential benefits of legalization, moved by a wide range of arguments on individual liberty but also by the prospective infusion of dollars into their respective economies. As this is occurring, proponents have quickly promoted marijuana as the medical prescription the states need to create new jobs, cut costs by keeping nonviolent drug offenders out of jail, and subsequently create a stream of revenue where there once was none.

American Cannabis Company in Business to Provide Solutions

One company putting its time, effort and resources into nearly every legal corner of the discussion is American Cannabis Company (OTCQB: AMMJ). American Cannabis Company, Inc. provides solutions for businesses operating in the cannabis industry in states and countries where cannabis is regulated and has been de-criminalized for medical use and/or legalized for recreational use. It offers consulting and advisory services and supplies products and equipment to businesses.

Much in the same way a distributor would provide education and training to a wholesaler about its products, AMMJ guides their clients through state and local cannabis business license application processes, designs and implements standard operating procedures and policies to ensure compliance with the legal regulations of the cannabis industry and assists clients in monitoring their business to ensure compliance with laws and regulations of the cannabis industry are met. It also educates and trains clients on the company’s processes and techniques for pharmaceutical grade cannabis in regulated commercial cultivation environments, advises and consults clients on the acquisition and start-up of cannabis businesses and researches, designs, develops, and markets products for the cannabis industry that enable the company’s customers to operate their cannabis business on a daily basis.

AMMJ has resources to address those interested in pursuing any commercial aspect of the cannabis business. Whether the individual’s business is medical or recreational commercial Cannabis cultivation and/or retail, experts at American Cannabis Company have the background and knowhow to ensure regulatory compliance and meet end user demands.

The Science and Art of Commercial Cultivation

In the area of commercial cannabis cultivation, the company assembles a knowledgeable team of professionals who can work with the client to build a cultivation system that meets regulatory guidelines while producing quality yields. Key aspects of the program include:

• A turnkey, commercial-scale grow operation, the Cultivation Cube provides environmental control, speed-to-market production, space efficiency, lean manufacturing and security.
• A 100-percent organic growing medium, named SoHum Soil, it prevents an improper balance of nutrients, improves plant immunity, and is more cost-effective than traditional soil and fertilizer growth methods.
• An automated irrigation watering system for reducing operator error, preventing inconsistent yields and conserving water through an electricity-free, gravity-based irrigation network.
• Named ‘The Satchel,’ this offering is a pouch-like case for Cannabis and Cannabis-infused products designed to meet regulatory compliance with laws requiring child-resistant exit packaging for licensed medicinal and recreational Cannabis businesses.

About American Cannabis Company, Inc.

American Cannabis Company owns and operates two vertically integrated businesses, American Cannabis Consulting and The Trade Winds Inc. These businesses deliver end-to-end solutions for their customers and clients within the cannabis industry. Through these businesses, AMMJ provides industry specific advisory and consulting services, manufactures cultivation products and facilities, and manages a strategic group partnership that supplies ancillary products. American Cannabis Company has successfully procured licensing agreements for its clients in several states and is accessing existing and new growth opportunities domestically and abroad.

AMMJ was co-founded by Corey Hollister and Ellis Smith, former owners of The Village Green Society in Boulder. These gentlemen were the first to cultivate medical cannabis on a commercial scale using a niche growing technique known as True Living Organics (TLO) producing pharmaceutical grade cannabis products for the Colorado patient market. Both Hollister and Smith received national recognition for this innovation, as well as for having helped the industry identify and develop mitigation protocols for new pest. Combined to this the company adds a team of seasoned professionals from sectors such as healthcare, agriculture, construction and engineering.

For more information, visit www.americancannabisconsulting.com

Delaine Corp.’s (DEPN) CarMonkey.com Demonstrates Strength with FY14 Performance

Friday, November 21st, 2014

Delaine, an e-retailer of automotive parts and services, launched its online store CarMonkeys.com little more than a year ago, and it didn’t take long for the online store to make its mark in the recycled automotive parts market.

CarMonkeys.com is an online car, van and SUV parts distributor of used automotive parts for a wide range of vehicle makes and models. In the first quarter of fiscal 2014 Delaine also launched LowMileageParts.com and advanced from “development stage.” Parts are shipped straight from one of the company’s many warehouses and auto dismantling centers straight to the customer or their mechanic.

Who wants to buy used automotive parts? Quite a few consumers, retailers, truck and car fleet owners and auto repair facilities, apparently.

In the company’s recently reported fiscal 2014 financial results for the period ended June 30, 2014, Delaine posted gross transactions volume at $1.85 million, compared to $61,000 for the prior-year period. Net revenue for fiscal 2014 increased to $672,858 compared to $3,210 for fiscal 2013. Delaine also increased its cash position to $123,331 in fiscal 2014 compared to $41,334 the prior year.

Fourth-quarter earnings of $198,000 and total assets growth of 44% effected growth in shareholder equity, which increased by 31%. A comparison of the fourth-quarter performance and the average of the first three quarters shows gross transaction volume growth of 43% and revenue growth of 25%.

Based on these results, auto industry trends and several corporate factors, Delaine is optimistic it will achieve “even greater increases in transaction volume and revenues.” The company anticipates it will benefit from a newly appointed chief operating officer with e-commerce experience, heightened marketing initiatives, repeat sales, additional product introductions, increased personnel to accommodate demand, and extended labor installation warranties.

For more information visit www.carmonkeys.com

Telecorp, Inc. (TLNUF): An Escalating Competitor in the Global SaaS Market

Thursday, November 13th, 2014

Telecorp is a communication solutions provider with an integrated suite of customized solutions that include customer acquisition, customer care, automated voice services, data management, webinars, customer support, voice messaging, e-mail, fax and text broadcasting, direct to voice mail messaging and much more.

The company competes in the rapidly expanding SaaS market, which is fire-balling toward $40.5 billion by 2014 from market value of $5.1 billion in 2007. According Gartner forecasts, SaaS will comprise approximately 25% of all corporate software sales within the next four years and represents more than 20% of the customer relationship management (CRM) market.

In addition to TelecorpVoIP, TelecorpSMS and TelecorpData, Telecorp’s current suite of products includes:

• I-driveSALES, a prospecting, customer management and telesales unit. This technology takes the best practices of call centers operations and allows those key features to be used for individuals and business;

• I-driveCONNECTS, an online communication system that delivers voice messages, e-mails, text messages and fax broadcasts to clients and potential clients. Telecorp has added a number of new state of the art features into I-driveCONNECTS which are not available in the marketplace;

• I-driveMEETINGS, a full online demonstration, meeting, training, webinars, support and customer service system. Using I-driveMEETINGS users can plan and schedule meetings, demos and training sessions quick and easy. Fully functional online support system which includes remote desktop tools, ticketing system, VoIP system and more;

• I-driveSTAFF, an exclusive front office software dedicated to staffing and recruiting firms of all sizes, where recruiting, sales and management experience the power of working together totally together through every office activity, from sales call to job order to placement to follow-up, anytime and from anyplace. I-driveSTAFF is 100% web-based and eliminates managing software, networks and servers.
Pioneering a new generation of technology, Telecorp has established a strong market position in Canada as well as a rapidly growing presence in the international market. The company generates sales through a multi-diverse system comprised of an interactive telesales department, distributor acquisition, aggressive referral program, advertising, direct mail and other traditional marketing avenues.

Telecorp intends to complete the development of domestic opportunities and to expand its market reach overseas in Europe, Australia and other global markets via planned joint-venture agreements. Telecorp has offices in New York, New York; Cheyenne, Wyoming; and Barrie, Ontario.

For more information visit www.telecorp.com

Let us hear your thoughts below:

BioElectronics Corp. (BIEL) Drug-Free, OTC Therapies on Target to Meet Affordable Pain Relief Demand

Thursday, November 13th, 2014

Life Science Intelligence (LSI) tells us pain is the single most common reason patients seek medical care and is attributable for approximately half of all physician office visits in the United States. Estimated economic impact of pain, disability and lost productivity costs equals $100 billion annually. In 2010, combined U.S. sales of pain management products (pharmaceuticals and devices) totaled approximately $33.1 billion. Over the forecast period covered in an LSI study, total sales of pain management products are expected to eclipse $38.2 billion this year.

BioElectronics is a company that understands the needs of the market and as a result has the know-how to introduce new ways to treat pain and inflammation. The company has developed a pain therapy that is effective, easy to use and is a localized treatment with no known adverse side effects. By leveraging electromagnetic diathermy which has been available for decades, BioElectronics has miniaturized the technology allowing the therapy to be used around the clock. What’s new is that this innovation has transformed the expensive, clinic based treatment, and made it affordable and available to be used every day. Because it is a simple localized treatment, it can be used as a standalone or adjunct therapy depending on the condition at hand. Clinical study has revealed that it is an effective therapy for both acute pain and chronic pain.

Founded in 2000, the company’s topical pain medical devices include ActiPatch therapy for over-the-counter treatment of back pain and other musculoskeletal complaints, Allay menstrual cycle pain therapy, RecoveryRx for chronic and post-operative wound care, and HealFast, a drug-free therapy for healing of muscle and tendon injuries, sores, and incision in horses, cats, and dogs. The company markets and sells its products under the ActiPatch, Allay, and RecoveryRx brand names through distributors primarily in Korea, Singapore, Canada, Columbia, Scandinavia, Malaysia, Saudi Arabia, the Balkans, China, South America and Australia.

In what can be viewed as a confirmation of the uniqueness of the company’s product line, BIEL recently announced that its Executive Vice President, Dr. Deepak Kotak has been invited to present BioElectronics’ innovative chronic pain therapy at the OTC Pharma Asia Conference in Singapore on March 3, 2015. Conference details can be found at www.otcpharmaasia.com.

Dr. Kotak plans to deliver a presentation entitled, “ActiPatch® Pain Therapy – Changing the Paradigm of OTC Chronic Pain.” The talk describes the science and how this OTC drug-free therapy is changing the way we view pain management and how it brings “life-changing relief” to those who suffer with chronic pain.

Dr. Kotak commented, “ActiPatch provides effective local pain treatment reducing the need for systemic therapies such as NSAID’s and opioids, and reduces the risk of side-effects and adverse events that are a burden to the chronic pain population. Our customers are reporting superior relief to most analgesics for conditions like fibromyalgia, back pain and arthritis.” As part Dr. Kotak’s presentation, he will also share his vision for BioElectronics technology and how it can be used to address a variety of other health care issues in society today.

BioElectronics is a leader in biophysics and the maker of a line of disposable, drug-free, pain therapy devices; ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy; and HealFast® Therapy for dogs, cats and horses.

For more information on the company, visit www.bielcorp.com

Let us hear your thoughts below:

Continental Stock Transfer & Trust Remains Sturdy Competitor amid Industry Consolidations

Tuesday, November 11th, 2014

During the last decade or so the stock transfer agency market has undergone considerable consolidation as smaller agencies exited the business or were acquired by larger agents. New technology, changing regulation and increasing competition also whittled the size of the playing filed into what is now an industry led by a small handful of vendors.

With healthy competition among the remaining players, companies seeking out a transfer agent can enjoy an easier selection process by vetting each agent’s customer service, price options and track record. Competition is divided into larger and smaller agencies, and what many small-cap companies discover is that bigger isn’t always better.

Mega transfer agents typically work with larger companies with hundreds of thousands of shareholders; certainly a valuable service to behemoth brands. Companies with 50,000 or fewer shareholders, however, benefit from the cost, personal attention, expertise and availability of a smaller agent such as Continental Stock Transfer & Trust. The agent’s award-winning, 50-year history bucks the notion that quality is compromised when delivered in a smaller package.

Continental offers the fundamentals and extended offerings you’d expect from a transfer agent that not only survived but gained strength throughout mass industry consolidation.

The agent offers comprehensive shareholder recordkeeping, transaction history, shareholder and stock activity reports, annual meeting management, dividend distribution, as well as industry-mandated services such as shareholder searches and escheatment. The agent also offers stock plan administration and services pertaining to corporate actions and escrow services. Continental has managed hundreds of IPOs and virtually all special-purpose acquisition companies (SPACs ) brought to market in the last 20 years.

Continental was founded in 1964 to fully support smaller to midsize emerging and growth companies with optimal client responsiveness and uniquely tailored business solutions. The agent has maintained this vision and commitment to this specific market throughout its history.

As the fourth-largest agent (again, among only a handful) in the United States, Continental offers something mega transfer agents cannot: an approach aptly focused on providing each company with personal attention from senior staff, flexible offerings and innovative technology. Annual industry surveys back Continental’s claims, year after year demonstrating the agent’s stellar track record of superior customer satisfaction.

For more information, visit www.continentalstock.com

Stellar Biotechnologies, Inc. (SBOTF) Schedules Year-End Conference Call

Thursday, November 6th, 2014

Earlier today, Stellar Biotechnologies announced that it will be hosting its end-of-year 2014 conference call and webcast at 1:30 PM ET (10:30 AM PT) on November 13, 2014.

Full details:

Date: Thursday, November 13, 2014
Time: 1:30 PM ET/ 10:30 AM PT
Participant Dial-in: 1-913-312-0380
Conference Call Participant Passcode: 9219736
Webcast Link: http://www.visualwebcaster.com/event.asp?id=100979
Q&A submission: Questions for management may be submitted via the chat feature of the live online webcast.

Participants are advised to log in at least 10 minutes prior to 1:30pm ET to ensure timely participation.

Those who are unable to attend the live conference call and webcast can access a recording at http://ir.stellarbiotechnologies.com/events-calendar. A replay of the call will be available approximately two hours after the live call through November 20, 2014.

Stellar Biotechnologies is the leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets. KLH is both an active pharmaceutical ingredient (API) in many new immunotherapies (targeting cancer, immune disorders, Alzheimer’s, and inflammatory diseases) as well as a finished product for measuring immune status. Stellar Biotechnologies is unique in its proprietary methods, facilities, and KLH technology. We are committed to meeting the growing demand for commercial-scale supplies of GMP grade KLH, ensuring environmentally sound KLH production, and developing KLH-based active immunotherapies.

For more information, visit www.StellarBiotech.com

Oriens Travel and Hotel Management, Inc. (OTHM) CEO Pereira Pens Fervent Letter to Shareholders

Tuesday, November 4th, 2014

Since Oriens Travel and Hotel Management’s former CEO resigned from his post in early September, the company has issued a series of announcements describing the advances of the company under the new leadership of current CEO Melvin Pereira.

In a recent letter to shareholders, the new chief executive contrasted Oriens’ beginnings to the direction in which he intends to guide the company.

To read the full letter visit http://orienscorp.wordpress.com/2014/11/03/the-entropy-of-oriens-part-i/

“Oriens stemmed from a very controlled idea. An idea of creating an impressive booking engine model that would be ahead of its time. A model that would take advantage of new internet protocols which would ultimately push Oriens branding and booking model to the forefront,” he writes in the letter.

“However, as soon as that purest idea was taken and introduced into the micro-cap public environment … BANG! Chaos ensued, and disorder began … My job is not to bring Oriens to its original state. No force in the known universe can reverse that kind of disorder. BUT, what I can do… and what WE will do together, is begin to shift the balance of disorder to order.”

In defending the company’s anticipated reverse split, Pereira states:

“I need the shareholders of Oriens to understand one thing. The Company as you once knew it, was in chaos. Oriens was holding an unimaginable amount of debt, with little to no assets, minimal revenue if any at all, and just enough incompetence at the executive level to cause a lot of discomfort. I am confident that this reverse split will cause far less discomfort in comparison, and support the true value that has already been delivered to the Company through this acquisition/merger.”

For more information on the company, visit www.orienscorp.com

Let us hear your thoughts: Oriens Travel and Hotel Management Corp. Message Board

Breast Cancer Awareness Beyond October

Friday, October 31st, 2014

Today, October 31st, marks the end of the National Breast Cancer Awareness Month (NBCAM) campaign. DreamTeamNetwork has supported and promoted this cause in a number of ways, including posting a series of blogs on breast cancer awareness.

We hope you’ve been reading and learning about the latest research and news concerning this disease. We also hope that whatever awareness you’ve gained this October endures beyond the month and year and into the future.

In that vein, we’d like to leave you with some parting words:

— As a global community, we all can benefit from a special reminder that breast cancer has no cure and cannot be ignored. It’s a disease that over 520,000 people worldwide and 40,000 people in the United States, mainly women but not exclusively so, die from each year.

— A major step you can take now in the fight against breast cancer is to do your research and learn more about the disease. Support organizations that are inspiring change through education and awareness. Visit the websites of major and minor breast cancer research organizations and advocacy groups.

— While most people are aware of breast cancer, many forget to take the steps to have a plan to detect the disease in its early stages or to encourage others to do the same. We could do more to change that.

— Too many people are wrestling with serious diseases year-round, not only breast cancer but other cancers and diseases as well. Dealing with these diseases can be overwhelming. We could do more to lend support.

— Patients should be informed of all of their options and given room to ask questions of their physicians. The best medical care happens when patients are educated about their condition and care options and share in decisions about their care.

In the end, cancer prevention is a collaborative effort. In support of the mothers, wives, sisters, daughters and women in our lives, we all can strive to inspire society to contribute to a healthier environment and, ultimately, a cancer-free world.

Let us hear your thoughts below:

Chembio Partners, Inc. (CEMI) Announces Partnership with BioTherapeutics, Inc. to Develop Point-of-Care Diagnostic Tests for Ebola and Febrile Illness

Monday, October 27th, 2014

Chembio Diagnostics, a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has entered into an exclusive agreement with Integrated BioTherapeutics, Inc. (IBT), a biotechnology company focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases. Under the terms of the agreement, Chembio will combine its patented DPP® technology with IBT’s proprietary Ebola reagents to develop POC diagnostic tests for Ebola and febrile illness. Chembio will have exclusive rights to any POC product developed through this agreement. Financial terms of the agreement were not disclosed.

While Ebola has caused multiple outbreaks since 1976, the frequency of epidemics in the past 15 years has drastically increased and the current outbreak in West Africa has reached unprecedented dimensions. Over 10,000 people have been infected with Ebola and recent cases outside the African continent are drawing concern from public health officials. Currently, the diagnosis of Ebola hemorrhagic fever can only be performed in specialized laboratories. This limitation significantly delays the identification and isolation of the patients who have Ebola and in turn likely makes it more difficult to control an outbreak or prevent new epidemics.

Javan Esfandiari, Chembio’s Chief Science & Technology Officer and the inventor of Chembio’s DPP® technology, commented, “We are pleased to partner with IBT, a biotechnology company with extensive experience and a substantial number of reagents for Ebola and other filoviruses, to develop a DPP® Ebola assay. In 2013, we partnered with the U.S. Government to develop a multiplex POC febrile illness assay which, in 20 minutes, can detect antigens from five different viruses, bacteria, and parasites with a single, finger-stick drop of blood. The resulting product, DPP® Febrile Illness Assay, is currently in clinical trials in several countries, including the region of West Africa. Our intent is to develop a stand-alone POC DPP® Ebola test and also include an Ebola test as part of our existing multiplex DPP® Febrile Illness Assay.”

John Sperzel, Chembio’s Chief Executive Officer, commented, “The partnership with IBT is a significant step in our continued efforts to expand Chembio’s POC infectious disease portfolio. Our prior success developing the multiplex DPP® Febrile Illness Assay demonstrates Chembio’s ability to create such tests in a short amount of time, and we believe this partnership illustrates the value that our DPP® technology brings to the broader diagnostic market. Through this agreement, Chembio’s goal is to further develop innovative, sensitive and specific POC diagnostic tests for detection of febrile illnesses, including Ebola.”

M. Javad Aman, President and Chief Scientific Officer of IBT, commented, “We are facing a humanitarian crisis and global public health challenge. Development of a rapid POC test for Ebola will be a critical step towards enabling early detection and quarantine that could help save countless lives. Through this partnership, the capabilities of the two companies will be combined to produce a POC product we believe will meet this serious challenge in a timely manner.”

For more information, visit www.chembio.com

Elite Pharmaceuticals, Inc. (ELTP) Announces New Management Appointees

Friday, October 24th, 2014

Elite Pharmaceuticals, a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche generic products, today reported new appointments to key management positions. Dr. Kennedy Smith, J.D., M.B.A. joins Elite as Vice President of Legal; Dr. Jason LePree as Vice President of Scientific Affairs; and Dr. Sophy Abraham as Vice President of Regulatory Affairs.

“We are pleased to welcome Ken, Jason, and Sophy to the Elite team and I’m thrilled with the caliber of expertise that these individuals bring to Elite,” said Nasrat Hakim, Elite’s President and Chief Executive Officer. “These additions greatly strengthen our management team in key areas and enhance our internal expertise in product development, regulatory compliance, and intellectual property to support the development of our opioid abuse deterrent products.”

Prior to his new role at Elite, Dr. Smith served as Chief Intellectual Property Counsel for Alpharma Incorporated. Before that, he was Head of North American Intellectual Property for Sanofi Aventis. In both roles, Dr. Smith held global responsibilities for intellectual property pertaining to multiple business units involved with many technologies. These included branded products, animal health products, active pharmaceutical ingredients, generic drugs, and vaccines. He also has a strong background in abuse deterrent intellectual property. Dr. Smith holds a Ph.D. in Biochemistry from University of Houston, an M.B.A from Lehigh University, and a J.D. from the University of Houston.

For his new role at Elite, Dr. LePree brings a wealth of experience in formulations, analytical research, and development. His previous position was Principal Scientist, Formulations Research and Development for Capsugel. Dr. LePree also draws upon a background in research and development, as he served in R&D positions at Abon Pharmaceuticals, Penwest Pharmaceuticals, Novartis, and Hoffman-LaRoche. With a B.S. in Pharmacy from Rutgers University and a Ph.D. in Pharmacy from the University of Wisconsin, he is also active in academia as an Adjunct Professor of Pharmacy at Long Island University.

Having worked over 20 years at Teva Pharmaceuticals, Dr. Abraham has significant regulatory and analytical experience. Prior to Elite, she served as Senior Regulatory Associate at Teva. Dr. Abraham holds a B.S. in Zoology, Botany, and Chemistry from the University of Kerala, India and a Ph.D. in Zoology from the University of Baroda, India.

For more information, visit www.elitepharma.com

Let us hear your thoughts below:

Shifting the Focus of Breast Cancer Awareness

Monday, October 20th, 2014

All throughout October 2014, DreamTeamNetwork will be posting a succession of blogs on breast cancer awareness, research and more news in support of the National Breast Cancer Awareness Month campaign. We are proud to show our continued support for this compassionate, laudable cause and hope you will too!

This year, we have been shining the light on a different kind of breast cancer awareness—a message more appropriate to today. Today’s message of awareness might adapt and shift focus in a number of different directions, including:

Emphasizing Unmet Needs
People with metastatic breast cancer are living an incredibly difficult existence with a long-term diagnosis. They go about their lives with an incurable condition, receiving treatment until death.

Pointing to Critical Areas for Research
Certain crucial areas to be researched include:

• Breast cancer’s causes – The more that is known about the causes of breast cancer, the more the cancer might be prevented;

• Metastases – The more is known about why secondary malignant growths develop at a distance from a primary site of cancer, the more these too might be prevented or better managed, if and/or when they arise;

• Better, more effective and less harmful treatments for all molecular subtypes of the disease; and

• Improvements in diagnostics or pathology so that patients with minimal or slow tumors can safely avoid overtreatment.

Stressing That Patients Have Options
Patients should be informed of all of their options and given room to ask questions of their physicians. The best medical care happens when patients are educated about their condition and care options, can enter the doctor’s office or clinic with a reasonable understanding of their condition and choices, and share in decisions about their care.

Recognizing That the World is Disease-ridden
Awareness is important but it also demands perspective, including the fact that breast cancer is one of many illnesses from which all kinds of people suffer and some die. There is no severity or merit contest for cancer. Each person in each situation deserves good medical care provided with respect and access to the necessary medication.

To take action and make a difference, consider supporting National Breast Cancer Foundation (www.nationalbreastcancer.org) or one of the many other organizations fighting against this deadly cancer.

Noble Financial / Capital Markets Equity Conference on Club Med, Sandpiper Bay, Florida’s Horizon

Monday, October 20th, 2014

Noble Financial / Capital Markets is in the midst of planning its 11th annual Equity Conference to be held January 18 – 21, 2015 at Club Med, Sandpaper Bay, Florida. This will be the second year in a row Noble has held the Equity Conference at the 220 acre resort. Sandpiper Bay is approximately 40 minutes from Palm Beach International Airport (PBI).

Called “the ultimate adventure in capitalism,” Noble will be host to one hundred fifty corporate executive teams and qualified institutional investors. The three-day program kicks off with a Sunday watch party featuring the AFC/NFC Championship NFL Games before continuing to formal presentations, cocktail receptions and one-on-ones. Also planned are scheduled executives / investors lunches and dinners, and three evening events that will expand the business day allowing for ample networking opportunities.

Registration includes all food and beverage and access to the club’s athletic and sporting amenities. Companies that register early have first call on the date and time of their presentations, a $1000 discount on the cost of registration, and allowance for one executive from each company to bring his or her spouse/partner at no additional cost.

Registrants can anticipate a spouse / partner & children’s program which promises to turn the conference into an enjoyable family experience. Noble encourages interested parties to plan early as space is limited as record attendance is expected. The conference marks the beginning of the company’s second decade of conferences (D2). Register today by going to www.nobleresearch.com/D2/2015.htm. For more information and a glimpse at the conference agenda please visit www.nobleresearch.com/D2/theAGENDA.htm.

Noble has been in the investment banking / capital markets business for nearly thirty years with its analysts and bankers averaging more than 25 years in the industry. The company has developed important verticals markets in technology, healthcare and media. Noble endeavors to be a market leader in the small-cap, emerging growth arena. Its strategy is to achieve this status by providing an ethical, timely, quality product to both its corporate partner and institutional investor customer base.

For more information on the company, visit www.nobleresearch.com

The 2015 ROTH Conference – It’s All about the Experience

Friday, October 17th, 2014

There is a place where hundreds of private equity investors, venture capitalists and institutional investors gather in the spring. It is a rich environment for business development opportunities in the small-cap and mid-cap space. It is the annual ROTH Conference.

The ROTH Conference is a must-see event, a powerfully effective marketing platform that brings together key decision makers within the U.S. and abroad. The conference was conceived to provide investors with unique opportunities where they could gain insight into emerging growth companies and is now considered one of the largest of its kind in the U.S. Last year’s event was even crowned one of the top business and financial industry events in the country.

The next ROTH Conference will be held on March 8-11, 2015 at The Ritz Carlton Laguna Niguel in Dana Point, California. It will be the 27th occurrence of the annual event.

Audience

In line with the success of previous years, next year’s conference will host over 3,000 attendees and nearly 500 participating companies.

Agenda

Over three and a half days, the event will present:

• 10 concurrent tracks of company presentations
• Thousands of one-on-one or small group meetings
• Numerous expert and thematic panel discussions
• A private track
• Three nights of signature evening entertainment

By the time the conference adjourns, it will have featured presentations from hundreds of public and private growth companies operating in a variety of sectors, including:

• Business Services
• Consumer
• E-Commerce and Retail
• Healthcare
• Industrials and Resources
• Media and Technology
• Solar and Cleantech

For more information about the conference, registration and sponsorship opportunities, visit www.roth.com

Let us hear your thoughts below:

Intelligent Highway Solutions, Inc. (IHSI) Pursues Greener Pastures

Friday, October 17th, 2014

Intelligent Highway Solutions is branching out. The developing Sacramento, California-based company is taking its vast knowledge of electrical solutions and applying them to new commercial ventures—of late, agricultural lighting systems and smart parking systems.

From the time it was established in 2011, IHSI has developed high and low voltage electrical solutions for commercial use as well as for various platforms—advanced lighting systems, electrical installations, temperature control systems and communication and wireless integration. Nowadays though, IHSI is using the latest technological developments to advance plant growing and commercial parking systems.

Agricultural Applications

IHSI holds exclusive distribution rights to lighting technologies that have the potential to improve yields and reduce costs for plant growers engaged in the legal cannabis industry. Consequently, the company has been offering its proprietary lighting systems as a leading solution for this booming sector.

With the installation of the company’s 300-watt lighting system, it is expected that medical cannabis growing facilities can generate larger, healthier yields of cannabis. The 300-watt lighting system is enhanced with increased lumens and photon density to achieve energy savings and provide the plant nursery with the necessary color spectrum and light to create an optimal growing environment. The company’s 100-watt system, which runs at a lower temperature, has also resulted in substantial energy reduction.

Commercial Parking Applications

Among IHSI’s offerings is a smart, wireless parking solution that could be used to improve the management of parking facilities at colleges, commercial lots, hospitals and municipal locations.

IHSI provides general and maintenance services for the assorted systems used for smart parking and so much more. Using proven technology, the company develops strategies that can be used to better manage the parking activities at large commercial garages and lots.

For more information, visit www.intelligenthighwaysolutions.com

Let us hear your thoughts: Intelligent Highway Solutions, Inc. Message Board

LD Micro Schedules 7th Annual Invitational Investor Conference for December 2-4

Wednesday, October 15th, 2014

LD Micro’s seventh annual Main Event investor conference is slated to take place December 2-4, 2014, at the Lux Hotel in Los Angeles, California. More than 230 companies have been invited to present at Main Event to showcase their unique positions and innovations to an audience of several hundred investors looking for trading ideas in the micro-cap space.

Established in 2002, LD Micro focuses on seeking-out undervalued companies in the micro-space and relaying its finds to the investment community via an annual publication of recommended stocks and comprehensive reports.

As part of its broader mission to help small-cap companies secure their spot on the map, LD Micro’s 7th Main Event will feature panel discussions, a keynote presentation by LD Micro founder Chris Lahiji, as well as evening cocktails for an environment of shared discussion and networking.

The conference will feature companies in a wide range of growth industries – from technology to biopharmaceuticals – that the broader markets may fail to recognize.

Learn more at www.ldmicro.com

Victura Construction Group, Inc. (VICT) is on the Front Lines after Catastrophic Events

Monday, October 13th, 2014

Last May marked the infamous, three-year anniversary of the EF-5 tornado that tore through Joplin, Missouri, just across the northeastern Oklahoma border. As one local reporter noted, the city, like Moore, Oklahoma, lost a hospital. The community’s health care facilities became symbols of overall recovery and revival.

Victura Construction Group is a holding company focused on strategic acquisitions within the construction industry that service the restoration and re-building needs that follow catastrophic events. The company in many ways can be considered a vital player in the overall recovery process through the deployment of solid business practices and management, ethics and financial resources where applicable. The foundation of VICT’s business model is driven through its leveraging of strategic industry relationships to help ensure success on behalf of company acquisitions.

VICT’s service niche becomes even more valuable following the overlay of post catastrophic event market statistics. Weather and climate disaster data strongly suggests construction expertise and resources following such an event not only have played a pivotal role in the economic and emotional rebuilding process but one whose relevance will continue grow and be relied upon following natural and technological disasters going forward. In 2013, there were 9 weather/climate disaster events with losses exceeding $1 billion each across the United States. These events included a drought event, 2 flooding events, and 6 severe storm events. Overall, these events resulted in the deaths of 113 people and had significant economic effects on the areas impacted. Given the daunting economic strain of such occurrences, the relevance of VICT’s business model becomes crucial.

While opportunity for players within the construction industry predictably mirrors economic indicators such as gross domestic product (GDP), housing starts and current employment statistics, Victura’s market opportunity is identified through occurrences which are ‘catastrophic’ by nature, making the target far more apparent and verifiable.

A common occurrence accounting for massive economic impact, both positive and negative, comes in the form of coastal area flooding. As we continue to refine and improve our country’s recovery mechanism, never before has the need for swift, proficient and cost effective renovation and re-build services been more apparent. Reuters reports that as sea levels rise, tidal flooding along the U.S. coast is likely to become so common that parts of many communities, including the nation’s capital, could become unusable within three decades, according to a new report from nonprofit science advocacy organization, Union of Concerned Scientists.

The report’s projections build on recent studies – including one by Reuters published last July – that documented a dramatic increase in tidal flooding over the past half century. Many coastal communities are already struggling to cope with routine flooding that makes streets impassable and overwhelms storm-water systems.

Using a methodology similar to those of the recent studies, scientists projected the trends 15 to 30 years into the future at 52 sites around the country. The study used moderate sea-level rise projections from the National Climate Assessment, a U.S. government report based on input from some 300 scientists, engineers, industry officials and other specialists.

With flooding being just one of dozens of events creating revenue opportunities for VICT, it is clear the company is doing well demonstrating the necessary experience and market sense to differentiate itself and seize burgeoning market opportunities to the benefit of its shareholders.

A Different Kind of Breast Cancer Awareness

Friday, October 10th, 2014

Throughout October, DreamTeamNetwork will be posting a series of blogs on topics dealing with breast cancer awareness, research and other news in support of National Breast Cancer Awareness Month (NBCAM). We are proud to show our support for this cause and hope you will too!

As the National Breast Cancer Awareness Month campaign marks another year, it may sometimes appear dated and unnecessary. For the advocates however, the need for more breast cancer awareness, research and better care hasn’t waned. Patients may have different needs and advocates different styles but patients also need support and researchers funds.

As a global community, we all can benefit from a special reminder that breast cancer has no cure and cannot be ignored. It is a disease that over 520,000 people worldwide and 40,000 people in the United States, mainly woman but not exclusively so, die from each year.

So, maybe what is needed this October then is a new kind of breast cancer awareness about details, such as the following:

• There are some parts of the world, including a few U.S. communities, where a stigma about having cancer endures. The existence of the NBCAM campaign may just lead a few women who are hesitant about seeking out care for breast tumors to go and get it.

• For some people affected with breast cancer, cheerful walks and other activities organized for NBCAM provide an opportunity to find solidarity and support.

• Too many people are wrestling with serious diseases year-round, not only breast cancer but other cancers and diseases as well. For all the good intentions and enthusiasm that NBCAM brings together, a heartening vibe sometimes runs counter to the overwhelming nature of the disease.

To take action and make a difference, consider supporting National Breast Cancer Foundation (www.nationalbreastcancer.org) or one of the many other organizations fighting against this deadly cancer.

Let us hear your thoughts below:

Sanomedics International Holdings (SIMH) Reduces Debt – Fortifies Path to Shareholder Value

Thursday, October 9th, 2014

Sanomedics International Holdings focuses on providing products, services and ideas through collaborative efforts between physicians, entrepreneurs, and medical companies. Together these groups bridge the gap between the high-technology medical world and the home healthcare environment. The net result is one that drives innovative technologies from concept to development, and ultimately revenue producing market sales. Sanomedics plans to grow its business through acquisitions, operating within the sleep disorder diagnosis treatments space. SIMH is active in its pursuit to acquire sleep therapy operating businesses. Its strategy involves integrating a portfolio of world-class products and service providers in the growing sleep apnea market. Its goal is to provide sleep apnea patients with a reliable “end-to-end” solution.

The market opportunity appears to be bright as sleep apnea is estimated to affect about 4% of men and 2% of women. In one study referenced at MedicineNet.com of people over 18 years of age, “obstructive sleep apnea was estimated to develop in 1.5% of people per year over the 5 year study. It is probably more common than either of these numbers because the population is becoming more obese, and obesity worsens obstructive sleep apnea.”

Within the highly competitive, preventative medicine marketplace, investors can rest assured Sanomedics is engaged in activity necessary for its financial health and viability. The company has just announced its liabilities have been reduced by 8% and in so doing has strengthened its balance sheet following the restructure of $1 Million, plus interest, in debt owed to TCA Global Credit Master Fund LP (“TCA”). The restructure of its TCA debt was announced in a press release and a Form 8-K filed with the Securities and Exchange Commission on September 29, 2014.

Sanomedics President, Keith Houlihan, added, “Our plans to build a solid foundation and strengthen the value of this company and its balance sheet, while garnering financial flexibility have not wavered in the slightest. Rather, they have been re-energized with this modest, but significant improvement in our liabilities. We remain committed to putting this company on the right path to long term growth and appreciation for benefit of not only Sanomedics and our shareholders, but also those in the healthcare industry that need innovative solutions to meet the patient care and safety demands that come with our growing and aging population.”

Additionally, SIMH designs, develops, markets, and distributes a line of non-contact clinical thermometers in the United States. The company’s products are served to the market under the Caregiver name to healthcare providers. This group includes hospitals, medical clinics, physician’s offices, assisted living facilities, acute care hospitals, and a variety of long-term care institutions. It sells its products through distributors, resellers, and sales representatives and is located in Miami, Florida.

For more information on the company, visit www.sanomedics.com

Let us hear your thoughts below:

QualityStocks is on the Apple App Store!

Tuesday, October 7th, 2014

Do you have an iPhone, iPad, or iPod Touch? If so, good news! You can access the latest micro-cap and small-cap news, in-depth articles on emerging growth companies, our currently featured companies, real-time Twitter updates and Facebook posts, and new “Ones to Watch!”

It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. Our team works very hard to bring the same high-quality content you expect from QualityStocks to your mobile devices.

To check out the new app, search for “QualityStocks” on your device or visit http://dtg.fm/qs-app